Cancer is a far reaching disease that requires a global response. According to the World Health Organization, more than 18 million people around the world are diagnosed with cancer every year.
To that end, Gateway is accelerating practice-changing discoveries in cancer care by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.
At Gateway, it is always and only about the patients we serve. Founded in 1991, Gateway is one of the only nonprofits solely dedicated to funding Phase I and II clinical trials for cancers of all types, urgently bringing breakthroughs to the bedside for courageous patients and their families.
Gateway invests in research that has the potential to forever change the face of cancer care through advancements in treatments and therapies that make a meaningful difference in the lives of patients. Thanks to the generosity of valued donors, we have achieved many significant breakthroughs in the quest to shape a world in which a cancer diagnosis is no longer feared.